Advanced search
Publication Cover
ClinicoEconomics and Outcomes Research Volume 13, 2021 - Issue
Submit an article Journal homepage
137
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Budgetary Impact of Bendamustine Ready-to-Dilute Products in Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma to a United States Infusion Facility

Elizabeth James1 Aventine Consulting LLC, Marblehead, MA, USACorrespondence[email protected]
,
Holly Trautman1 Aventine Consulting LLC, Marblehead, MA, USA
,
Stephen Thompson2 Global Health Economics and Outcomes Research, Teva Branded Pharmaceutical Products R&D, Inc, Parsippany, NJ, USA
,
Rinat Ribalov3 Global Health Economics and Outcomes Research, Teva Pharmaceutical Industries Ltd, Petah Tikva, Israel
&
Azhar Choudhry4 Medical Affairs, Teva Branded Pharmaceutical Products R&D, Inc, Parsippany, NJ, USA
Pages 201-211 | Published online: 22 Mar 2021

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.